Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-01-03 Sale |
2023-01-04 5:16 pm |
Oyster Point Pharma Inc. | OYST | Behbahani Ali Director |
13,639 | $0 | $0 | 0 (Direct) |
View |
| 2023-01-03 Sale |
2023-01-04 5:10 pm |
Oyster Point Pharma Inc. | OYST | WEISNER AIMEE S Director |
36,764 | $0 | $0 | 0 (Direct) |
View |
| 2023-01-03 Sale |
2023-01-04 5:08 pm |
Oyster Point Pharma Inc. | OYST | Tsai Benjamin Director |
3,573 | $0 | $0 | 0 (Direct) |
View |
| 2023-01-03 Sale |
2023-01-04 5:08 pm |
Oyster Point Pharma Inc. | OYST | Santel Donald J Director |
8,198 | $0 | $0 | 0 (Direct) |
View |
| 2023-01-03 Sale |
2023-01-04 5:07 pm |
Oyster Point Pharma Inc. | OYST | Ozawa Clare Director |
14,637 | $0 | $0 | 0 (Indirect Direct) |
View |
| 2023-01-03 Sale |
2023-01-04 5:06 pm |
Oyster Point Pharma Inc. | OYST | Nau Jeffrey President and CEO |
48,975 | $0 | $0 | 0 (Indirect Direct) |
View |
| 2023-01-03 Sale |
2023-01-04 5:05 pm |
Oyster Point Pharma Inc. | OYST | Murray Mark Anthony Director |
122,086 | $0 | $0 | 0 (Direct) |
View |
| 2023-01-03 Sale |
2023-01-04 5:04 pm |
Oyster Point Pharma Inc. | OYST | Lochner Daniel Chief Financial Officer |
20,236 | $0 | $0 | 0 (Direct) |
View |
| 2023-01-03 Sale |
2023-01-04 5:03 pm |
Oyster Point Pharma Inc. | OYST | Eliades George Christopher Director |
28,624 | $0 | $0 | 0 (Direct) |
View |
| 2023-01-03 Sale |
2023-01-04 5:02 pm |
Oyster Point Pharma Inc. | OYST | ATIEH MICHAEL G Director |
8,671 | $0 | $0 | 0 (Direct) |
View |
| 2021-10-18 Sale |
2021-10-20 4:38 pm |
Oyster Point Pharma Inc. | OYST | Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC Versant Ventures IV LLC Versant Venture Capital IV L.P. Versant Side Fund IV L.P. 10% Owner |
550,000 | $14.84 | $8,160,736 | 3,245,533 (Indirect Direct) |
View |
| 2021-10-18 Sale |
2021-10-20 4:32 pm |
Oyster Point Pharma Inc. | OYST | LINK WILLIAM J PHD Director |
550,000 | $14.84 | $8,160,736 | 64,872 (Indirect Direct) |
View |
| 2021-10-18 Sale |
2021-10-20 4:31 pm |
Oyster Point Pharma Inc. | OYST | Ozawa Clare Director 10% Owner |
550,000 | $14.84 | $8,160,736 | 3,256,357 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-01-03 Equity Swap |
2023-01-05 4:30 pm |
N/A N/A |
Oyster Point Pharma Inc. | OYST | InvOpps GP IV L.L.C. InvOpps IV L.P. InvOpps IV US L.P. LAINOVIC SACHA Director 10% Owner |
2,768,586 | $0 | 0 (Indirect) |
View |
| 2023-01-03 Equity Swap |
2023-01-04 6:11 pm |
N/A N/A |
Oyster Point Pharma Inc. | OYST | Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC Versant Ventures IV LLC Versant Venture Capital IV L.P. Versant Side Fund IV L.P. 10% Owner |
3,657,618 | $0 | 0 (Direct) |
View |
| 2023-01-03 Equity Swap |
2023-01-04 5:14 pm |
N/A N/A |
Oyster Point Pharma Inc. | OYST | New Enterprise Associates 14 L.P. BASKETT FOREST KERINS PATRICK J NEA 14 GP LTD NEA Partners 14 L.P. SANDELL SCOTT D Sonsini Peter W. 10% Owner |
5,925,287 | $0 | 0 (Direct) |
View |
| 2023-01-03 Equity Swap |
2023-01-04 5:08 pm |
N/A N/A |
Oyster Point Pharma Inc. | OYST | Tsai Benjamin Director |
10,066 | $0 | 0 (Direct) |
View |
| 2023-01-03 Equity Swap |
2023-01-04 5:08 pm |
N/A N/A |
Oyster Point Pharma Inc. | OYST | Santel Donald J Director |
5,489 | $0 | 0 (Direct) |
View |
| 2023-01-03 Equity Swap |
2023-01-04 5:07 pm |
N/A N/A |
Oyster Point Pharma Inc. | OYST | Ozawa Clare Director |
3,657,618 | $0 | 0 (Indirect) |
View |
| 2023-01-03 Equity Swap |
2023-01-04 5:06 pm |
N/A N/A |
Oyster Point Pharma Inc. | OYST | Nau Jeffrey President and CEO |
100,738 | $0 | 0 (Direct) |
View |
| 2022-01-29 Tax Withholding |
2023-01-04 5:06 pm |
N/A N/A |
Oyster Point Pharma Inc. | OYST | Nau Jeffrey President and CEO |
2,607 | $11.7 | 0 (Direct) |
View |
| 2023-01-03 Equity Swap |
2023-01-04 5:04 pm |
N/A N/A |
Oyster Point Pharma Inc. | OYST | Lochner Daniel Chief Financial Officer |
56,289 | $0 | 0 (Direct) |
View |
| 2022-01-29 Tax Withholding |
2023-01-04 5:04 pm |
N/A N/A |
Oyster Point Pharma Inc. | OYST | Lochner Daniel Chief Financial Officer |
938 | $11.7 | 0 (Direct) |
View |
| 2023-01-03 Equity Swap |
2023-01-04 5:02 pm |
N/A N/A |
Oyster Point Pharma Inc. | OYST | ATIEH MICHAEL G Director |
18,063 | $0 | 0 (Direct) |
View |
| 2022-12-01 Tax Withholding(A) |
2022-12-06 7:05 pm |
N/A N/A |
Oyster Point Pharma Inc. | OYST | Nau Jeffrey President and CEO |
8,938 | $11.2 | 149,660 (Direct) |
View |
| 2022-12-01 Tax Withholding |
2022-12-06 08:50 am |
N/A N/A |
Oyster Point Pharma Inc. | OYST | Lochner Daniel Chief Financial Officer |
3,258 | $11.2 | 74,463 (Direct) |
View |
| 2022-12-01 Tax Withholding |
2022-12-05 5:36 pm |
N/A N/A |
Oyster Point Pharma Inc. | OYST | Nau Jeffrey President and CEO |
6,217 | $11.2 | 152,381 (Direct) |
View |
| 2022-07-06 Option Award |
2022-07-08 4:55 pm |
N/A 2032-07-05 |
Oyster Point Pharma Inc. | OYST | Lochner Daniel Chief Financial Officer |
300,000 | $0 | 300,000 (Direct) |
View |
| 2022-07-06 Option Award |
2022-07-08 4:54 pm |
N/A 2032-07-05 |
Oyster Point Pharma Inc. | OYST | Nau Jeffrey President and CEO |
350,000 | $0 | 350,000 (Direct) |
View |
| 2022-06-06 Option Award |
2022-06-08 4:49 pm |
N/A 2032-06-05 |
Oyster Point Pharma Inc. | OYST | Behbahani Ali Director |
8,932 | $0 | 18,998 (Direct) |
View |
| 2022-06-06 Option Award |
2022-06-08 4:49 pm |
N/A 2032-06-05 |
Oyster Point Pharma Inc. | OYST | Ozawa Clare Director |
8,932 | $0 | 3,677,614 (Direct) |
View |
| 2022-06-06 Option Award |
2022-06-08 4:48 pm |
N/A 2032-06-05 |
Oyster Point Pharma Inc. | OYST | Eliades George Christopher Director |
8,932 | $0 | 33,983 (Direct) |
View |
| 2022-06-06 Option Award |
2022-06-08 4:47 pm |
N/A 2032-06-05 |
Oyster Point Pharma Inc. | OYST | WEISNER AIMEE S Director |
8,932 | $0 | 42,123 (Direct) |
View |
| 2022-06-06 Option Award |
2022-06-08 4:46 pm |
N/A 2032-06-05 |
Oyster Point Pharma Inc. | OYST | Tsai Benjamin Director |
8,932 | $0 | 18,998 (Direct) |
View |
| 2022-06-06 Option Award |
2022-06-08 4:45 pm |
N/A 2032-06-05 |
Oyster Point Pharma Inc. | OYST | Murray Mark Anthony Director |
8,932 | $0 | 127,445 (Direct) |
View |
| 2022-06-06 Option Award |
2022-06-08 4:44 pm |
N/A 2032-06-05 |
Oyster Point Pharma Inc. | OYST | ATIEH MICHAEL G Director |
8,932 | $0 | 32,093 (Direct) |
View |
| 2022-06-06 Option Award |
2022-06-08 4:43 pm |
N/A 2032-06-05 |
Oyster Point Pharma Inc. | OYST | Santel Donald J Director |
8,932 | $0 | 19,046 (Direct) |
View |
| 2022-01-09 Option Award |
2022-01-11 7:47 pm |
N/A 2032-01-08 |
Oyster Point Pharma Inc. | OYST | Snisarenko John Chief Commercial Officer |
66,600 | $0 | 84,822 (Direct) |
View |
| 2022-01-09 Option Award |
2022-01-11 7:46 pm |
N/A 2032-01-08 |
Oyster Point Pharma Inc. | OYST | Nau Jeffrey President and CEO |
256,700 | $0 | 368,598 (Direct) |
View |
| 2022-01-09 Option Award |
2022-01-11 7:45 pm |
N/A 2032-01-08 |
Oyster Point Pharma Inc. | OYST | Lochner Daniel Chief Financial Officer |
107,400 | $0 | 165,621 (Direct) |
View |
| 2022-01-05 Other |
2022-01-07 6:08 pm |
N/A N/A |
Oyster Point Pharma Inc. | OYST | LINK WILLIAM J PHD Director |
6,839 | $0 | 463,993 (Indirect) |
View |
| 2022-01-05 Other |
2022-01-07 4:20 pm |
N/A N/A |
Oyster Point Pharma Inc. | OYST | Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC Versant Ventures IV LLC Versant Venture Capital IV L.P. Versant Side Fund IV L.P. 10% Owner |
253,030 | $0 | 3,547,597 (Indirect) |
View |
| 2022-01-05 Other |
2022-01-07 4:18 pm |
N/A N/A |
Oyster Point Pharma Inc. | OYST | Ozawa Clare Director 10% Owner |
253,150 | $0 | 3,558,781 (Indirect) |
View |
| 2021-12-21 Other |
2021-12-23 5:34 pm |
N/A N/A |
Oyster Point Pharma Inc. | OYST | LINK WILLIAM J PHD Director |
6,838 | $0 | 665,065 (Indirect) |
View |
| 2021-12-21 Other |
2021-12-23 4:43 pm |
N/A N/A |
Oyster Point Pharma Inc. | OYST | Ozawa Clare Director 10% Owner |
253,150 | $0 | 3,559,922 (Indirect) |
View |
| 2021-12-21 Other |
2021-12-23 4:40 pm |
N/A N/A |
Oyster Point Pharma Inc. | OYST | Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC Versant Ventures IV LLC Versant Venture Capital IV L.P. Versant Side Fund IV L.P. 10% Owner |
253,030 | $0 | 3,548,858 (Indirect) |
View |
| 2021-11-01 Exercise |
2021-11-02 5:49 pm |
N/A N/A |
Oyster Point Pharma Inc. | OYST | Lochner Daniel Chief Financial Officer |
8,590 | $11.51 | 219,472 (Direct) |
View |
| 2021-11-01 Exercise |
2021-11-02 5:49 pm |
N/A 2029-07-25 |
Oyster Point Pharma Inc. | OYST | Lochner Daniel Chief Financial Officer |
8,590 | $0 | 219,472 (Direct) |
View |
| 2021-10-21 Exercise |
2021-10-22 4:41 pm |
N/A 2027-11-10 |
Oyster Point Pharma Inc. | OYST | Nau Jeffrey President and CEO |
50,000 | $0 | 546,672 (Direct) |
View |
| 2021-10-21 Exercise |
2021-10-22 4:41 pm |
N/A N/A |
Oyster Point Pharma Inc. | OYST | Nau Jeffrey President and CEO |
50,000 | $1.02 | 546,672 (Direct) |
View |